Gilead To Pay Up To $120M For CGI Pharmaceuticals
Biopharmaceutical company Gilead Sciences Inc. has agreed to buy privately held drug discovery company CGI Pharmaceuticals Inc. for up to $120 million, in a deal that broadens the reach of Gilead's...To view the full article, register now.
Already a subscriber? Click here to view full article